The Impact of COVID-19 is included in the Interventional Cardiology and Peripheral Vascular Device Market in Switzerland.
Buy it today to get an advantage. Request the impact of COVID-19 on your product or industry
The future of the interventional cardiology and peripheral vascular device market in Switzerland looks promising with opportunities in hospitals and ambulatory surgical centers. The major drivers for the growth of this market include the growing elderly population, a rise in the prevalence of chronic diseases, advancements in medical technology and research, improvement of healthcare infrastructure in developing countries, and change in lifestyles.
Emerging trends which have a direct impact on the dynamics of the interventional cardiology and peripheral vascular device industry include rising adoption of TAVR procedures, increasing use of bioresorbable stents, and a rise in adoption of drug eluting balloons.
A total of 25 figures / charts and 12 tables are provided in this 60-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of this interventional cardiology and peripheral vascular device market in Switzerland report, download the report brochure.
Interventional Cardiology and Peripheral Vascular Device Market in Switzerland by Segment:
2014-2025 (US $M) (Randomized Data) Trends and Forecasts for Interventional Cardiology and Peripheral Vascular Device Market in Switzerland:
2014-2025 (US $M) (Randomized Data)
The study includes market size and forecast for the interventional cardiology and peripheral vascular device market in Switzerland through 2025, segmented by type, device, and end use as follows:
Interventional Cardiology and Peripheral Vascular Device Market by Type [Value ($ Million) from 2014 to 2025]:
-
Interventional Cardiology Device
-
Peripheral Vascular Device
Interventional Cardiology and Peripheral Vascular Device Market by Device Type [Value ($ Million) from 2014 to 2025]:
-
Angioplasty Balloons
-
Angioplasty Stents
-
Angioplasty Catheters
-
EVAR stent graft
-
IVC filter
-
Embolic Protection Devices
-
Guidewires
-
Arteriotomy Closure Devices
-
Intravascular Ultrasound System (IVUS)
-
Synthetic Surgical Graft
Interventional Cardiology and Peripheral Vascular Device Market by End Use [Value ($ Million) from 2014 to 2025]:
-
Hospitals
-
Ambulatory Surgical Centers
On the basis of comprehensive research, Lucintel forecasts that the EVAR stent graft segment will show above average growth during the forecast period.
By end use, the interventional cardiology and peripheral vascular device market is segmented into hospitals and ambulatory surgical centers. The hospital segment is expected to remain the largest segment in the forecast period as hospitals have a much higher budget than ambulatory surgical centers.
Some of the features of “Opportunities for the Interventional Cardiology and Peripheral Vascular Device Market in Switzerland 2014-2025: Trends, Forecast and Competitive Analysis” include:
-
Market size estimates: Interventional cardiology and peripheral vascular device market size estimation in terms of value ($M) shipment.
-
Trend and forecast analysis: Market trend (2014-2019) and forecast (2020-2025) by type, device, and end use.
-
Segmentation analysis: Interventional cardiology and peripheral vascular device market size by various applications such as type, device, and end use in terms of value and volume shipment.
-
Growth opportunities: Analysis on growth opportunities in different type, device, and end use of interventional cardiology and peripheral vascular device in the interventional cardiology and peripheral vascular device market.
-
Análisis de la intensidad competitiva de la industria basada en el modelo de cinco fuerzas de Porter.
This report addresses the following 7 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the interventional cardiology and peripheral vascular device market in Switzerland by type (interventional cardiology device and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent grafts, IVC filters, embolic protection devices, guidewires, arteriotomy closure devices, intravascular ultrasound systems (IVUS), and synthetic surgical grafts), and end use (hospitals and ambulatory surgical centers)?
Q.2. Which product segment will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this interventional cardiology and peripheral vascular device market?
Q.4. What are the business risks and competitive threats in this interventional cardiology and peripheral vascular device market?
Q.5. What are the emerging trends in this interventional cardiology and peripheral vascular device market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the interventional cardiology and peripheral vascular device market?
Q.7. What are the new developments in the interventional cardiology and peripheral vascular device market and which companies are leading these developments?